A number of organizations have developed or are developing psychedelic integration groups, held in
person or online. In parallel, there have been calls to make enhanced integration available in the
community after clinical trials. Here, we explore a potential reason why individuals may seek out
these groups: namely, the feelings of disconnection and loneliness that may arise after the psychedelic
experience (noting that there may be other reasons that individuals may seek out these groups).
Integration groups can offer significant benefits to participants (e.g. a sense of community, shared
coping strategies); however, there may also be a number of associated risks. In this essay, we aim to
explore the benefits and risks of integration groups, and offer a preliminary set of guidelines to
physicians, researchers and individuals to help assess and evaluate these groups.
